Jean Monnet University
14
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Assessment of the Increased Risk of Infection Following an Ultratrail
Role: collaborator
Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
Role: collaborator
Effect of Sleep Extension in Prevention to Sleep Deprivation
Role: collaborator
Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells
Role: collaborator
Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery
Role: collaborator
Social Marketing in Prevention Actions
Role: collaborator
Development of a Developmental Prognostic Tool for the Premature Child Based on Automated Spontaneous Motor Analysis
Role: collaborator
Study of Recovery and Blood Rheology Changes in Ultra-endurance Runners (ERUPTION-3)
Role: collaborator
Promoting Fall Prevention Workshops
Role: collaborator
Predictors Associated With Maintaining Driving in Old Age
Role: collaborator
Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy
Role: collaborator
Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
Role: collaborator
Prediction of Clinical Course in COVID19 Patients
Role: collaborator
Acceptability, Representations and Experiences of the COVID-19 Pandemic
Role: collaborator
All 14 trials loaded